Analysis of the Bactericidal Response to an Experimental Neisseria meningitidis Vesicle Vaccine
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Analysis of the Bactericidal Response to an Experimental Neisseria meningitidis Vesicle Vaccine
Authors
Keywords
-
Journal
Clinical and Vaccine Immunology
Volume 19, Issue 5, Pages 659-665
Publisher
American Society for Microbiology
Online
2012-03-30
DOI
10.1128/cvi.00070-12
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epidemiology and Risk Factors for Serogroup X Meningococcal Meningitis during an Outbreak in Western Kenya, 2005–2006
- (2018) David M. Mutonga et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- A Critical Threshold of Meningococcal Factor H Binding Protein Expression Is Required for Increased Breadth of Protective Antibodies Elicited by Native Outer Membrane Vesicle Vaccines
- (2011) Oliver Koeberling et al. Clinical and Vaccine Immunology
- Emergence of Epidemic Neisseria meningitidis Serogroup X Meningitis in Togo and Burkina Faso
- (2011) Isabelle Delrieu et al. PLoS One
- An experimental outer membrane vesicle vaccine from N. meningitidis serogroup B strains that induces serum bactericidal activity to multiple serogroups
- (2011) Valerian B. Pinto et al. VACCINE
- A phase 1 study of a meningococcal native outer membrane vesicle vaccine made from a group B strain with deleted lpxL1 and synX, over-expressed factor H binding protein, two PorAs and stabilized OpcA expression
- (2011) P.B. Keiser et al. VACCINE
- Three Doses of an Experimental Detoxified L3-Derived Lipooligosaccharide Meningococcal Vaccine Offer Good Safety but Low Immunogenicity in Healthy Young Adults
- (2010) P. Bonvehi et al. Clinical and Vaccine Immunology
- Multicenter, Open‐Label, Randomized Phase II Controlled Trial of an Investigational Recombinant Meningococcal Serogroup B Vaccine With and Without Outer Membrane Vesicles, Administered in Infancy
- (2010) Jamie Findlow et al. CLINICAL INFECTIOUS DISEASES
- Design and evaluation in mice of a broadly protective meningococcal group B native outer membrane vesicle vaccine
- (2010) Wendell D. Zollinger et al. VACCINE
- Distribution of factor H binding protein beyond serogroup B: Variation among five serogroups of invasive Neisseria meningitidis in South Africa
- (2010) Kedibone M. Mothibeli et al. VACCINE
- Characterization of an Antibody Depletion Assay for Analysis of Bactericidal Antibody Specificity
- (2009) W. D. Zollinger et al. Clinical and Vaccine Immunology
- Quadrivalent Meningococcal Vaccination of Adults: Phase III Comparison of an Investigational Conjugate Vaccine, MenACWY-CRM, with the Licensed Vaccine, Menactra
- (2009) K. S. Reisinger et al. Clinical and Vaccine Immunology
- Genetically Modified L3,7 and L2 Lipooligosaccharides from Neisseria meningitidis Serogroup B Confer a Broad Cross-Bactericidal Response
- (2009) V. Weynants et al. INFECTION AND IMMUNITY
- Meningococcal Factor H–Binding Protein Variants Expressed by Epidemic Capsular Group A, W‐135, and X Strains from Africa
- (2009) P. T. Beernink et al. JOURNAL OF INFECTIOUS DISEASES
- Chemistry of a new investigational quadrivalent meningococcal conjugate vaccine that is immunogenic at all ages
- (2009) Michael Bröker et al. VACCINE
- Specificity of Subcapsular Antibody Responses in Ethiopian Patients following Disease Caused by Serogroup A Meningococci
- (2008) G. Norheim et al. Clinical and Vaccine Immunology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now